Zobrazeno 1 - 10
of 161
pro vyhledávání: '"Julie Irving"'
Autor:
Uri Ilan, Judith M. Boer, Birgit Burkhardt, Frederik van Delft, Shai Izraeli, Jan-Henning Klusmann, Barbara De Moerloose, Pablo Velasco, Julie Irving, José Luis Fuster, Dániel Erdélyi, Andreas E Kulozik, Dirk Reinhardt, Michel Zwaan, Monique L. den Boer
Publikováno v:
HemaSphere, Vol 7, p e86945e6 (2023)
Externí odkaz:
https://doaj.org/article/f1708f804c6f49fcb9464343c4404e9d
Autor:
Marcela B. Mansur, Caroline L. Furness, Sirintra Nakjang, Amir Enshaei, Donat Alpar, Sue M. Colman, Lynne Minto, Julie Irving, Beth V. Poole, Elda P. Noronha, Suvi Savola, Sameena Iqbal, John Gribben, Maria S. Pombo‐de‐Oliveira, Tony M. Ford, Mel F. Greaves, Frederik W. vanDelft
Publikováno v:
Cancer Medicine, Vol 10, Iss 14, Pp 4864-4873 (2021)
Abstract Background Treatment on risk adapted intensive pediatric protocols has improved outcome for teenagers and young adults (TYA) with T‐cell acute lymphoblastic leukemia (T‐ALL). Understanding the biology of disease in this age group and the
Externí odkaz:
https://doaj.org/article/7d97ea0a9eda427ea4c2aec1f542ddc1
Autor:
Sarah Johnson, Geoff Shenton, Ruth Plummer, Joshua Savage, Gareth J Veal, Julie Irving, Lucinda Billingham, Pamela Kearns, Daniel Slade, Tobias Menne, Britta Vormoor, Josef Vormoor
Publikováno v:
BMJ Open, Vol 12, Iss 3 (2022)
Introduction Event-free survival rates at 15 years for paediatric patients with relapsed/refractory acute lymphoblastic leukaemia (ALL) are 30%–50%, with 5-year survival for adult patients only 20%. Many patients with newly diagnosed and relapsed A
Externí odkaz:
https://doaj.org/article/b59e18f2d4664a4b942cd501f73730b6
Autor:
Klaus Rehe, Kerrie Wilson, Simon Bomken, Daniel Williamson, Julie Irving, Monique L. den Boer, Martin Stanulla, Martin Schrappe, Andrew G. Hall, Olaf Heidenreich, Josef Vormoor
Publikováno v:
EMBO Molecular Medicine, Vol 5, Iss 1, Pp 38-51 (2012)
Abstract Leukaemia‐propagating cells are more frequent in high‐risk acute B lymphoblastic leukaemia than in many malignancies that follow a hierarchical cancer stem cell model. It is unclear whether this characteristic can be more universally app
Externí odkaz:
https://doaj.org/article/3ee2949e211147f2b1d225b60f8a3078
Autor:
Kerrie Wilson, Marian Case, Lynne Minto, Simon Bailey, Nick Bown, Jenny Jesson, Sarah Lawson, Josef Vormoor, Julie Irving
Publikováno v:
Haematologica, Vol 95, Iss 4 (2010)
Flow cytometric minimal residual disease (MRD) monitoring could become more powerful if directed towards the disease-maintaining leukemic stem cell (LSC) compartment. Using a cohort of 48 children with B-lineage acute lymphoblastic leukemia (ALL), we
Externí odkaz:
https://doaj.org/article/4045b2fb08cf492babe125c42fb00b21
Autor:
Julie Irving, Jenny Jesson, Paul Virgo, Marian Case, Lynne Minto, Lisa Eyre, Nigel Noel, Ulrika Johansson, Marion Macey, Linda Knotts, Margaret Helliwell, Paul Davies, Liam Whitby, David Barnett, Jeremy Hancock, Nick Goulden, Sarah Lawson
Publikováno v:
Haematologica, Vol 94, Iss 6 (2009)
Minimal residual disease detection, used for clinical management of children with acute lymphoblastic leukemia, can be performed by molecular analysis of antigen-receptor gene rearrangements or by flow cytometric analysis of aberrant immunophenotypes
Externí odkaz:
https://doaj.org/article/addd4a6fb56a4df8b98a9a2c05de8ed8
Autor:
Amy Jamieson, Jutta Huvila, Samuel Leung, Derek Chiu, Emily F. Thompson, Amy Lum, Mary Kinloch, Limor Helpman, Shannon Salvador, Danielle Vicus, Sarah Kean, Vanessa Samouelian, Katherine Grondin, Julie Irving, Saul Offman, Carlos Parra-Herran, Susie Lau, Stephanie Scott, Marie Plante, Melissa K. McConechy, David G. Huntsman, Aline Talhouk, Stefan Kommoss, C. Blake Gilks, Jessica N. McAlpine
Publikováno v:
Gynecologic Oncology. 170:282-289
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd8d792520d15b9c25e23f3489ca05ae
https://doi.org/10.1016/j.ygyno.2023.01.025
https://doi.org/10.1016/j.ygyno.2023.01.025
Autor:
Emily F. Thompson, Jutta Huvila, Amy Jamieson, Samuel Leung, Amy Lum, Saul Offman, Alice Lytwyn, Mona Lisa Sur, Lynn Hoang, Julie Irving, Nicholas van der Westhuizen, Chantale Morin, Cyrille Bicamumpaka, Nazilla Azordegan, François Gougeon, Kaoutar Ennour-Idrissi, Janine Senz, Melissa K. McConechy, Rosalia Aguirre-Hernandez, Victoria Lui, Carolyn Kuo, Cassidy Bell, Taylor Salisbury, James Lawson, Ellen He, Shanzhao Wang, Derek Chiu, Sarah Kean, Vanessa Samouëlian, Shannon Salvador, Walter Gotlieb, Limor Helpman, Stephanie Scott, Christoph Wohlmuth, Danielle Vicus, Marie Plante, Aline Talhouk, David Huntsman, Carlos Parra-Herran, Mary Kinloch, Katherine Grondin, C. Blake Gilks, Jessica N. McAlpine, Jessica McAlpine, Anita Agrawal, Omar Al-Nourhji, Alon Altman, Marcus Bernardini, C. Bicamumpaka, Mark Carey, Blaise Clarke, Nazila Azordegan, Bojana Djordjevic, Laurie Elit, Alex Ferenczy, Sarah Finlayson, Anthony Fyles, Hugo Garneau, France Gauthier, Prafull Ghatage, Blake Gilks, Kathy Han, Hal Hirte, Fleur Huang, Katharina Kieser, Mary Kinlloch, Iwa Kong, Aalok Kumar, Janice Kwon, Sandra Lee, Eric Leung, Helen Mackay, Eve-Lyne Marchand, Justin Mcginnis, Dianne Miller, Gregg Nelson, Manuela Pelmus, Annick Pina, Anna Plotkin, Diane Provencher, Anna Tinker, Alicia Tone, Stephen Welch, Nicholas Westhuizen, Katarzyna Jerzak
Publikováno v:
Modern Pathology. 35:1974-1982
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21ba941ca766a49ef2842e5b6df53618
https://doi.org/10.1038/s41379-022-01165-w
https://doi.org/10.1038/s41379-022-01165-w
Autor:
Neil T. Thompson, David R. Newell, Christopher Murray, Julie Irving, John Lyons, Eddy Freyne, Edward J. Lewis, Jose Cosme, Andrew Pike, Brent L. Graham, Lindsay A. Devine, Susanne Bethell, Abarna Thiru, Ruth Feltell, Darcey Miller, Maria Carr, Sharna Rich, Michael A. Batey, Christopher Hamlett, Michael Reader, Martyn Frederickson, Alistair O'Brien, Emma Vickerstaffe, Rajdeep K. Benning, Andrew Madin, Charlotte Griffiths Jones, Douglas Ross, Lynsey Fazal, Tim Perera, Patrick Angibaud, Peter King, Anne Cleasby, Valerio Berdini, Gordan Saxty, George Ward, Matthew Squires
We describe here the identification and characterization of 2 novel inhibitors of the fibroblast growth factor receptor (FGFR) family of receptor tyrosine kinases. The compounds exhibit selective inhibition of FGFR over the closely related VEGFR2 rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::605eebdec9c9d2137ffcbba68a3b82cd
https://doi.org/10.1158/1535-7163.c.6535227
https://doi.org/10.1158/1535-7163.c.6535227
Autor:
Neil T. Thompson, David R. Newell, Christopher Murray, Julie Irving, John Lyons, Eddy Freyne, Edward J. Lewis, Jose Cosme, Andrew Pike, Brent L. Graham, Lindsay A. Devine, Susanne Bethell, Abarna Thiru, Ruth Feltell, Darcey Miller, Maria Carr, Sharna Rich, Michael A. Batey, Christopher Hamlett, Michael Reader, Martyn Frederickson, Alistair O'Brien, Emma Vickerstaffe, Rajdeep K. Benning, Andrew Madin, Charlotte Griffiths Jones, Douglas Ross, Lynsey Fazal, Tim Perera, Patrick Angibaud, Peter King, Anne Cleasby, Valerio Berdini, Gordan Saxty, George Ward, Matthew Squires
PDF file - 475K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fe1a33d4a31585a984d85c6194526c9
https://doi.org/10.1158/1535-7163.22496319
https://doi.org/10.1158/1535-7163.22496319